AU2020901858A0 - Compounds and Methods for the Treatment of Eye Disorders - Google Patents

Compounds and Methods for the Treatment of Eye Disorders

Info

Publication number
AU2020901858A0
AU2020901858A0 AU2020901858A AU2020901858A AU2020901858A0 AU 2020901858 A0 AU2020901858 A0 AU 2020901858A0 AU 2020901858 A AU2020901858 A AU 2020901858A AU 2020901858 A AU2020901858 A AU 2020901858A AU 2020901858 A0 AU2020901858 A0 AU 2020901858A0
Authority
AU
Australia
Prior art keywords
compounds
treatment
methods
eye disorders
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020901858A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OCCURX Pty Ltd
Original Assignee
OCCURX Pty Ltd
Filing date
Publication date
Application filed by OCCURX Pty Ltd filed Critical OCCURX Pty Ltd
Publication of AU2020901858A0 publication Critical patent/AU2020901858A0/en
Priority to EP21818477.8A priority Critical patent/EP4161527A1/en
Priority to JP2022574480A priority patent/JP2023529845A/en
Priority to CN202180056862.4A priority patent/CN116033901A/en
Priority to PCT/US2021/035749 priority patent/WO2021247900A1/en
Priority to US18/007,714 priority patent/US20230270703A1/en
Priority to PCT/US2021/035750 priority patent/WO2021247901A1/en
Priority to KR1020237000380A priority patent/KR20230024331A/en
Priority to IL298733A priority patent/IL298733A/en
Priority to AU2021284380A priority patent/AU2021284380A1/en
Priority to MX2022015327A priority patent/MX2022015327A/en
Priority to CA3185849A priority patent/CA3185849A1/en
Priority to BR112022024728A priority patent/BR112022024728A2/en
Pending legal-status Critical Current

Links

AU2020901858A 2020-06-05 2020-06-05 Compounds and Methods for the Treatment of Eye Disorders Pending AU2020901858A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
BR112022024728A BR112022024728A2 (en) 2020-06-05 2021-06-03 COMPOUNDS AND METHODS FOR TREATMENT OF OPHTHALMOLOGICAL DISORDERS
US18/007,714 US20230270703A1 (en) 2020-06-05 2021-06-03 Compounds and methods for the treatment of eye disorders
JP2022574480A JP2023529845A (en) 2020-06-05 2021-06-03 Compounds and methods for the treatment of ocular disorders
CN202180056862.4A CN116033901A (en) 2020-06-05 2021-06-03 Compounds and methods for treating ocular disorders
PCT/US2021/035749 WO2021247900A1 (en) 2020-06-05 2021-06-03 Compounds and methods for the treatment of eye disorders
EP21818477.8A EP4161527A1 (en) 2020-06-05 2021-06-03 Compounds and methods for the treatment of eye disorders
PCT/US2021/035750 WO2021247901A1 (en) 2020-06-05 2021-06-03 Compounds and methods for the treatment of eye disorders
KR1020237000380A KR20230024331A (en) 2020-06-05 2021-06-03 Compounds and methods for the treatment of eye disorders
IL298733A IL298733A (en) 2020-06-05 2021-06-03 Compounds and methods for the treatment of eye disorders
AU2021284380A AU2021284380A1 (en) 2020-06-05 2021-06-03 Compounds and methods for the treatment of eye disorders
MX2022015327A MX2022015327A (en) 2020-06-05 2021-06-03 Compounds and methods for the treatment of eye disorders.
CA3185849A CA3185849A1 (en) 2020-06-05 2021-06-03 Compounds and methods for the treatment of eye disorders

Publications (1)

Publication Number Publication Date
AU2020901858A0 true AU2020901858A0 (en) 2020-06-18

Family

ID=

Similar Documents

Publication Publication Date Title
EP3931189A4 (en) Azepino-indoles and other heterocycles for treating brain disorders
EP4013403A4 (en) Methods of treating psychological and brain disorders
EP3955937A4 (en) Compounds and methods for the treatment of ocular disorders
EP3999085A4 (en) Methods and products for treatment of gastrointestinal disorders
EP3955926A4 (en) Compounds and methods for the treatment of ocular disorders
EP3999084A4 (en) Methods and products for treatment of gastrointestinal disorders
EP3651747A4 (en) Compositions and methods for the treatment of eye disorders
EP3976182A4 (en) Modulating the effects of gamma-c-cytokine signaling for the treatment of alopecia and alopecia associated disorders
EP3761970A4 (en) Compositions and methods for the treatment of neurological diseases
EP3810777A4 (en) Compositions and methods for the treatment and prevention of neurological disorders
EP3826650A4 (en) Methods of treating neurological disorders
EP3969597A4 (en) Compositions and methods for the treatment of atpase-mediated diseases
EP3826649A4 (en) Methods of treating neurological disorders
EP3755319A4 (en) Compounds and compositions for the treatment of muscular disorders
EP4034109A4 (en) Method and composition for the treatment of disease
EP3927428A4 (en) Methods of treatment of respiratory disorders
EP4010075A4 (en) Methods for the treatment of apoc3-related diseases and disorders
EP3709982A4 (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
EP3955914A4 (en) Novel compounds and methods of use treating fructose-related disorders or diseases
EP4010347A4 (en) Compositions and methods for the treatment of pain and dependance disorders
EP3813794A4 (en) Ophthalmic compositions and methods for the treatment of eye disorders
EP4069847A4 (en) Treatment of lower airways disorders
EP3962545A4 (en) Compositions and methods for the treatment of retinal degeneration
EP3938364A4 (en) Compounds for and methods of treating diseases
EP3990457A4 (en) Compounds for treatment of eye disorders